Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Search results

52 items matching your search terms.
Stromal cell diversity associated with immune evasion in human triple-negative breast cancer
Wu, S. Z.; Roden, D. L.; Wang, C.; Holliday, H.; Harvey, K.; Cazet, A. S.; Murphy, K. J.; Pereira, B.; Al-Eryani, G.; Bartonicek, N.; Hou, R.; Torpy, J. R.; Junankar, S.; Chan, C. L.; Lam, C. E.; Hui, M. N.; Gluch, L.; Beith, J.; Parker, A.; Robbins, E.; Segara, D.; Mak, C.; Cooper, C.; Warrier, S.; Forrest, A.; Powell, J.; O'Toole, S.; Cox, T. R.; Timpson, P.; Lim, E.; Liu, X. S.; Swarbrick, A.
EMBO JOURNAL 1 (39) :e104063, 2020 10.15252/embj.2019104063
Testosterone therapy considerations in oestrogen, progesterone and androgen receptor-positive breast cancer in a transgender man
Light, M.; McFarlane, T.; Ives, A.; Shah, B.; Lim, E.; Grossmann, M.; Zajac, J. D.; Cheung, A. S.
CLINICAL ENDOCRINOLOGY 93 (3) :355-357, 2020 10.1111/cen.14263
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
Portman, N.; Milioli, H. H.; Alexandrou, S.; Coulson, R.; Yong, A.; Fernandez, K. J.; Chia, K. M.; Halilovic, E.; Segara, D.; Parker, A.; Haupt, S.; Haupt, Y.; Tilley, W. D.; Swarbrick, A.; Caldon, C. E.; Lim, E.
BREAST CANCER RESEARCH 22 (1) :87, 2020 10.1186/s13058-020-01318-2
OpenAccess publication Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
Baker, L. A.; Holliday, H.; Roden, D.; Krisp, C.; Wu, S. Z.; Junankar, S.; Serandour, A. A.; Mohammed, H.; Nair, R.; Sankaranarayanan, G.; Law, A. M. K.; McFarland, A.; Simpson, P. T.; Lakhani, S.; Dodson, E.; Selinger, C.; Anderson, L.; Samimi, G.; Hacker, N. F.; Lim, E.; Ormandy, C. J.; Naylor, M. J.; Simpson, K.; Nikolic, I.; O'Toole, S.; Kaplan, W.; Cowley, M. J.; Carroll, J. S.; Molloy, M.; Swarbrick, A.
BREAST CANCER RES 22 (1) :63, 2020 10.1186/s13058-020-01306-6
Targeting CDK2 in cancer: challenges and opportunities for therapy
Tadesse, S.; Anshabo, A. T.; Portman, N.; Lim, E.; Tilley, W.; Caldon, C. E.; Wang, S.
DRUG DISCOVERY TODAY 25 (2) :406-413, 2020 10.1016/j.drudis.2019.12.001
Window of opportunity treatment in breast cancer
Chen, J.; Easwaralingam, N.; Warrier, S.; Ong, A.; Carson, E. K.; Mak, C.; Snook, K.; Middleton, K.; Parker, A.; Palmieri, C.; Spillane, A.; Mann, G. B.; Lim, E.; Segara, D.
ANZ JOURNAL OF SURGERY 90 (1-2) :34-40, 2020 10.1111/ans.15487
Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: position statement summary
Grossmann, M.; Ramchand, S. K.; Milat, F.; Vincent, A.; Lim, E.; Kotowicz, M. A.; Hicks, J.; Teede, H. J.
MEDICAL JOURNAL OF AUSTRALIA 211 (5) :224-229, 2019 10.5694/mja2.50280
OpenAccess publication Estrogen receptor signaling is reprogrammed during breast tumorigenesis
Chi, D.; Singhal, H.; Li, L.; Xiao, T.; Liu, W.; Pun, M.; Jeselsohn, R.; He, H.; Lim, E.; Vadhi, R.; Rao, P.; Long, H.; Garber, J.; Brown, M.
The International Academy of Cytology Yokohama system for reporting breast fine-needle aspiration biopsy cytopathology
Field, A. S.; Raymond, W. A.; Rickard, M.; Arnold, L.; Brachtel, E. F.; Chaiwun, B.; Chen, L.; Di Bonito, L.; Kurtycz, D. F. I.; Lee, A. H. S.; Lim, E.; Ljung, B. M.; Michelow, P.; Osamura, R. Y.; Pinamonti, M.; Sauer, T.; Segara, D.; Tse, G.; Vielh, P.; Chong, P. Y.; Schmitt, F.
ACTA CYTOL 63 (4) :257-273, 2019 10.1159/000499509
OpenAccess publication Immunoprofiling of breast cancer antigens using antibodies derived from local lymph nodes
Young, A. R.; Duarte, J. D. G.; Coulson, R.; O'Brien, M.; Deb, S.; Lopata, A.; Behren, A.; Mathivanan, S.; Lim, E.; Meeusen, E.
Cancers 11 (5) :682, 2019 10.3390/cancers11050682
OpenAccess publication Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer
Kennedy, S. P.; Han, J. Z. R.; Portman, N.; Nobis, M.; Hastings, J. F.; Murphy, K. J.; Latham, S. L.; Cadell, A. L.; Miladinovic, D.; Marriott, G. R.; O'Donnell, Y. E. I.; Shearer, R. F.; Williams, J. T.; Munoz, A. G.; Cox, T. R.; Watkins, D. N.; Saunders, D. N.; Timpson, P.; Lim, E.; Kolch, W.; Croucher, D. R.
BREAST CANCER RESEARCH 21 (1) :43, 2019 10.1186/s13058-019-1127-y
OpenAccess publication The proliferative and apoptotic landscape of basal-like breast cancer
Alexandrou, S.; George, S. M.; Ormandy, C. J.; Lim, E.; Oakes, S. R.; Caldon, C. E.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 (3) :667, 2019 10.3390/ijms20030667
Overcoming CDK4/6 inhibitor resistance in ER positive breast cancer
Portman, N.; Alexandrou, S.; Carson, E.; Wang, S.; Lim, E.; Caldon, C. E.
ENDOCRINE-RELATED CANCER 26 :R15-R30, 2019 10.1530/erc-18-0317
The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis
Lee, K. W. C.; Lord, S.; Finn, R. S.; Lim, E.; Martin, A.; Loi, S.; Lynch, J.; Friedlander, M.; Lee, C. K.
BREAST CANCER RESEARCH AND TREATMENT 174 (1) :271-278, 2019 10.1007/s10549-018-5054-x
Non-canonical AR activity facilitates endocrine resistance in breast cancer
Chia, K.; Milioli, H.; Portman, N.; Laven-Law, G.; Coulson, R.; Yong, A.; Segara, D.; Parker, A.; Caldon, C. E.; Deng, N.; Swarbrick, A.; Tilley, W. D.; Hickey, T. E.; Lim, E.
ENDOCRINE-RELATED CANCER 26 (2) :251-264, 2019 10.1530/erc-18-0333
Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
Boyle, F.; Beith, J.; Burslem, K.; de Boer, R.; Hui, R.; Lim, E.; McCarthy, N.; Redfern, A.; Woodward, N.
Asia-Pacific Journal of Clinical Oncology 14 Suppl 4 :3-11, 2018 10.1111/ajco.13064